Demand for star anti-cancer drugs is strong, AstraZeneca's Q1 revenue and profits exceeded expectations.

Zhtng cijng APP huxn, shu mngxng kng'i yow xqi de tudng, slkng (AZN.US) d y jdun lrn zngzhng cho yq. Ci bo xinsh, slkng (AZN.US) d y jdun zng yngshu 152.88 y miyun, tngb zngzhng 8%, choch shchng yq; tiozhng hu mi g shuy wi 2.58 miyun, go y fnxsh yq de 2.55 miyun. According to the Zhtng Cijng APP, driven by the demand for star anti-cancer drugs, AstraZeneca (AZN.US) saw a higher-than-expected increase in profits in the first quarter. The financial report shows that AstraZeneca's total revenue in the first quarter was $15.288 billion, an 8% year-on-year increase, exceeding market expectations; adjusted earnings per share were $2.58, higher than analysts' expectations of $2.55.